Items Tagged ‘James Watson’

February 28, 2012

Confirmation: Low-Dose Naltrexone Eases Fibromyalgia Pain

By Mystery User

A new study, reported here at the American Academy of Pain Medicine 28th Annual Meeting, shows that a low dose of the opioid antagonist naltrexone significantly reduces daily pain in patients with fibromyalgia…Asked to comment on the findings, session moderator James Watson, MD, from the Mayo Clinic in Rochester, Minnesota, said that “it is pretty […]

View full entry

Tags: 28th Annual Meeting, American Academy of Pain Medicine, Fibromyalgia, James Watson, opioid antagonist naltrexone


February 28, 2012

Sacroiliac Steroid Injections Do Not Predict Ablation Relief

By Mystery User

One quarter of patients with chronic sacroiliac joint pain may be disqualified from receiving radiofrequency ablation (RFA) treatment based on inaccurate criteria for patient selection, a new study suggests…”It does fly in the face of what we typically do,” commented session moderator James Watson, MD, from the Mayo Clinic in Rochester, Minnesota. “It suggests we […]

View full entry

Tags: chronic sacroiliac joint pain, James Watson, radiofrequency ablation, RFA


Contact Us · Privacy Policy